For life sciences
Only 3–5% of adults with cancer enroll in a trial.Rivvi closes the gap.
Most adults with cancer never hear about a trial they qualify for. Rivvi turns each match into a reached, consented conversation: first contact, pre-screening, and status write-back across voice, text, and chat.
8 countries live · Spanish + 30 languages · HIPAA BAA · SOC 2 Type II · Adverse events routed on every conversation
MassiveBio
17,912
oncologist-confirmed matches
Massive Bio's neuro-symbolic matching, evaluated prospectively in 3,804 patients, reported more than 17,000 oncologist-confirmed matches. Rivvi carries those matches into consent-aware conversations at national scale.
- 500K+
- patients reached
- 2M+
- interactions
The architecture
Identify, engage, act.
IDENTIFY
the intelligence layer
Consented clinical and biomarker data becomes explainable patient-trial matches, prioritized cohorts, and next-best-action signals. Your matching engine, or a partner's, tells us who and why.
ENGAGE
where Rivvi runs
A single orchestrator agent turns each match into a governed, auditable workflow: first-contact outreach, barrier discovery, pre-screening, scheduling, and consent capture, in the patient's language, with defined human-escalation paths.
ACT
the human layer
Clinicians, navigators, and sites receive structured context to complete the next appropriate step, from a prescreening discussion to an appointment or a patient-support action. Clinical judgment stays with clinicians.
Programs
What we run for life sciences teams
One coordinated outreach layer across patient support programs, hub services, and study sites, configured to your protocols and your systems of record.
Patient support
Hub & PSP enrollment
Reach referred patients, confirm eligibility and benefits, and enroll them into your support program, with anything clinical routed to your coordinators.
Clinical trials
Study pre-screening
Work the candidate list against your protocol's screening questions, route qualified participants to the site, and keep the ones who aren't ready warm.
Adherence
Therapy start & persistence
Follow patients through the critical first fills and check-ins that keep them on therapy, on their schedule, inside consent and TCPA rules.
Coordination
Status back to the hub
Every contact, screen result, and status change writes back to your hub platform, Salesforce, or CRM, so your team sees the loop close without chasing it.
Adverse events
Detected on every conversation, routed inside the window
Adverse events are detected on every call, text and chat, transcribed, and routed to the person you name, inside your reporting window, on every program. Consent, HIPAA and TCPA handling have been in production for years, not added for this.
One case, both sides
The handoff is where cases die
A patient approved by the hub and dispensed by the pharmacy is one patient. Rivvi already knows where the case has been, what was said, what consent was captured and what's outstanding, so the second call doesn't reintroduce itself to somebody who enrolled last week. One consent record, not two. Each brand program keeps its own data, agent identity and reporting.
Questions
What life sciences teams ask first
What does Rivvi do for life sciences?
Rivvi runs first-contact outreach, pre-screening, therapy persistence check-ins, and status write-back for patient support programs, hub services, and study sites, across voice, text, and web chat, with adverse-event routing on every conversation.
How does the Massive Bio partnership work?
Massive Bio provides prospectively validated oncology intelligence; Rivvi is the agentic action layer that turns each match into governed outreach and coordination.
Do we need a new EHR integration?
No. Rivvi deploys without requiring a new electronic medical record integration. It connects to the hubs, CRMs, and workflows you already run, and writes every outcome back.
More on how the rules bind: Security and compliance